PRJNA553546 - Reprogramming of bivalent chromatin states in NRAS-mutant melanoma suggests PRC2 inhibition as a therapeutic strategy - OmicsDI

Genomics

Dataset Information

Reprogramming of bivalent chromatin states in NRAS-mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

ABSTRACT: Reprogramming of bivalent chromatin states in NRAS-mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

PROVIDER: PRJNA553546 | ENA |

REPOSITORIES: ENA